
Kerna Labs develops improved genetic medicines by applying artificial intelligence to design and optimize therapeutic constructs. The company uses AI-driven design and predictive modeling to refine genetic sequences and anticipate therapeutic performance. Kerna Labs operates as a biotech therapeutics developer, leveraging machine learning as its core technology. Its platform targets development of next-generation gene and nucleic acid therapies for clinical and research applications.

Kerna Labs develops improved genetic medicines by applying artificial intelligence to design and optimize therapeutic constructs. The company uses AI-driven design and predictive modeling to refine genetic sequences and anticipate therapeutic performance. Kerna Labs operates as a biotech therapeutics developer, leveraging machine learning as its core technology. Its platform targets development of next-generation gene and nucleic acid therapies for clinical and research applications.